Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Acrux Limited ( (AU:ACR) ) has shared an announcement.
Acrux Limited announced that all resolutions at their Extraordinary General Meeting were passed as ordinary resolutions through a poll. This positive outcome could enhance Acrux’s operational flexibility and support their strategic initiatives in the pharmaceutical industry, potentially benefiting stakeholders through new product developments and partnerships.
More about Acrux Limited
Acrux Limited is a pharmaceutical company focused on developing and commercializing topical pharmaceuticals. With 25 years of experience and in-house capabilities, the company has successfully launched several products in the US and Europe through licensees. Acrux is working on a range of generic products for the US market and is open to collaboration and partnership for product development.
YTD Price Performance: 10.0%
Average Trading Volume: 500
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $8.03M
See more insights into ACR stock on TipRanks’ Stock Analysis page.
